Maslimomab Explained

Maslimomab is a mouse monoclonal antibody[1] and an immunosuppressive drug.[2] It is an anti-human T-cell receptor alpha/beta chain.

Notes and References

  1. Proposed International Nonproprietary Names: Maslimomab . WHO Drug Information . 5 . 4 . 1991 . 201 . Geneva . World Health Organization . https://web.archive.org/web/20120223171347/http://apps.who.int/medicinedocs/index/assoc/h5791e/h5791e.pdf . 23 February 2012 . dead.
  2. Book: Pelletier JP, Mukhtar F . Passive monoclonal and polyclonal antibody therapies. . Immunologic Concepts in Transfusion Medicine . January 2020 . 251–348 (299) . Elsevier . Philadelphia . 978-0-323-67510-9 . 7153350 . 10.1016/B978-0-323-67509-3.00016-0 . https://books.google.com/books?id=4PWrDwAAQBAJ&dq=Maslimomab&pg=PA299 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Maslimomab".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.